CTOs on the Move


 
As the intraoperative imaging expert, IMRIS, Deerfield Imaging measurably improves patient outcomes through planning, product integration and clinical workflow to give surgeons access to diagnostic quality scans in operating room suites. The IMRIS Surgical Theatre, which uniquely transport MR and CT scanners to the patient using ceiling-mounted rails and incorporate other IMRIS imaging technology, are sold globally to hospitals that deliver clinical services to patients in neurosurgical, spinal, interventional and orthopedic markets.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.imris.com
  • 5101 Shady Oak Rd
    Minnetonka, MN USA 55343
  • Phone: 763.203.6300

Executives

Name Title Contact Details

Similar Companies

Axelgaard Manufacturing Co

Founded in 1985, Axelgaard Manufacturing Co., Ltd. (AMC) has grown to become the premier manufacturer of neurostimulation electrodes. Our primary brand is our patented PALS Neurostimulation Electrodes. We are dedicated to providing the highest quality

MPRO

MPRO is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

M*Modal

M*Modal offers a new breed of speech understanding applications. Our hosted conversational documentation services help healthcare providers capture clinical information from dictation and transform it directly into accessible, retrievable, and shareable electronic files. M*Modal serves hospitals, medical clinics, and medical transcription companies representing a transaction volume of more than 400 million dictation minutes a year.

Specific Diagnostics

Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Revealâ„¢ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific`s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.

Blue Note Therapeutics

Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better.